The stock market is down Wednesday, with the Dow Jones Industrial Average down 0.12%, the Nasdaq down 0.76% and the S&P 500 down 0.42%. Today’s only winner is a pharmaceutical company that has been in correction for the past two days. Meanwhile, one of today’s losers had a subsidiary that withdrew an initial public offering, while another loser is a pharmaceutical company that delayed publishing the results of a study.
These are Wednesday’s market winner and losers.
Biggest Winner
Shares of Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) are up 6.45% to $1.81 on trading volume of 11.9 million shares. Shares have rebounded for the last two days after the stock price lost the majority of its value Monday after discrepancies with a lung cancer drug test. The 52-week high is $5.50.
Biggest Losers
Shares of Blyth Inc. (NYSE: BTH) are down 16.64% to $27.15 on trading volume of 1.4 million shares. ViSalus, a subsidiary of Blyth that sells nutritional supplements, withdrew its proposed IPO due to market uncertainty. The 52-week low is $25.62.
Shares of Catalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) are down 10.76% to $1.64 on trading volume of 2.9 million shares. The mid-stage results of a cocaine addiction study were delayed. The 52-week low is 50 cents.
Samuel Weigley
Follow him on Twitter: SWeigley
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
